Skip to content
10-Q

Quarterly Report

THESEUS PHARMACEUTICALS, INC.

0001745020-23-000080

← back to feed
Filed
Nov 17, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 10, 2023 44.23M sh
Shares Diluted Q3 2023 · Sep 30, 2023 43.8M sh
Shares Diluted Q3 2023 · Sep 30, 2023 43.31M sh
Shares Diluted Q3 2023 · Sep 30, 2022 38.59M sh
Shares Diluted Q3 2023 · Sep 30, 2022 38.42M sh
Capex Q3 2023 · Sep 30, 2023 $61K
Capex Q3 2023 · Sep 30, 2022 $444K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$39.7M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$23.01M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $46.89M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $94.61M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $115.56M
Stockholders Equity Q3 2023 · Sep 30, 2023 $224.52M
Stockholders Equity Q3 2023 · Jun 30, 2023 $234.08M
Stockholders Equity Q3 2023 · Mar 31, 2023 $245.49M
Stockholders Equity Q3 2023 · Dec 31, 2022 $207.62M
Stockholders Equity Q3 2023 · Sep 30, 2022 $218.59M
Stockholders Equity Q3 2023 · Jun 30, 2022 $229M
Stockholders Equity Q3 2023 · Mar 31, 2022 $237.85M
Stockholders Equity Q3 2023 · Dec 31, 2021 $246.43M
Current Liabilities Q3 2023 · Sep 30, 2023 $7M
Current Liabilities Q3 2023 · Dec 31, 2022 $11.13M
Total Liabilities Q3 2023 · Sep 30, 2023 $10.11M
Total Liabilities Q3 2023 · Dec 31, 2022 $14.83M
Current Assets Q3 2023 · Sep 30, 2023 $209.59M
Current Assets Q3 2023 · Dec 31, 2022 $202.12M
Total Assets Q3 2023 · Sep 30, 2023 $234.63M
Total Assets Q3 2023 · Dec 31, 2022 $222.45M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.31
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.99
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.38
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.96
Eps Basic Q3 2023 · Sep 30, 2023 −$0.31
Eps Basic Q3 2023 · Sep 30, 2023 −$0.99
Eps Basic Q3 2023 · Sep 30, 2022 −$0.38
Eps Basic Q3 2023 · Sep 30, 2022 −$0.96
Sga Expense Q3 2023 · Sep 30, 2023 $4.88M
Sga Expense Q3 2023 · Sep 30, 2023 $14.21M
Sga Expense Q3 2023 · Sep 30, 2022 $4.53M
Sga Expense Q3 2023 · Sep 30, 2022 $13.29M
Rd Expense Q3 2023 · Sep 30, 2023 $11.52M
Rd Expense Q3 2023 · Sep 30, 2023 $36.84M
Rd Expense Q3 2023 · Sep 30, 2022 $11.42M
Rd Expense Q3 2023 · Sep 30, 2022 $25.32M
Net Income Q3 2023 · Sep 30, 2023 −$13.5M
Net Income Q3 2023 · Sep 30, 2023 −$42.9M
Net Income Q3 2023 · Jun 30, 2023 −$14.81M
Net Income Q3 2023 · Mar 31, 2023 −$14.59M
Net Income Q3 2023 · Sep 30, 2022 −$14.75M
Net Income Q3 2023 · Sep 30, 2022 −$36.89M
Net Income Q3 2023 · Jun 30, 2022 −$11.65M
Net Income Q3 2023 · Mar 31, 2022 −$10.5M
Operating Income Q3 2023 · Sep 30, 2023 −$16.4M
Operating Income Q3 2023 · Sep 30, 2023 −$51.05M
Operating Income Q3 2023 · Sep 30, 2022 −$15.95M
Operating Income Q3 2023 · Sep 30, 2022 −$38.61M